82_FR_13399 82 FR 13353 - National Institute of Arthritis and Musculoskeletal and Skin Diseases; Notice of Closed Meeting

82 FR 13353 - National Institute of Arthritis and Musculoskeletal and Skin Diseases; Notice of Closed Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 82, Issue 46 (March 10, 2017)

Page Range13353-13354
FR Document2017-04710

Federal Register, Volume 82 Issue 46 (Friday, March 10, 2017) 
[Federal Register Volume 82, Number 46 (Friday, March 10, 2017)]
[Notices]
[Pages 13353-13354]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2017-04710]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Arthritis and Musculoskeletal and Skin 
Diseases; Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Arthritis and 
Musculoskeletal and Skin Diseases Special Emphasis Panel; Ancillary 
Studies.
    Date: March 27, 2017.
    Time: 10:00 a.m. to 1:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institute of Arthritis and Musculoskeletal and 
Skin Diseases, National Institutes of Health, Democracy One, 
Bethesda, MD 20892 (Telephone Conference Call).
    Contact Person: Yin Liu, Ph.D., MD, Scientific Review Officer, 
Scientific Review Branch, National Institute of Arthritis and 
Musculoskeletal and Skin Diseases, NIH, 6701 Democracy Boulevard, 
Suite 824, Bethesda, MD 20892, 301-594-4952, [email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.846, 
Arthritis, Musculoskeletal and Skin Diseases Research, National 
Institutes of Health, HHS)


[[Page 13354]]


    Dated: March 6, 2017.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2017-04710 Filed 3-9-17; 8:45 am]
 BILLING CODE 4140-01-P

Federal Register / Vol. 82, No. 46 / Friday, March 10, 2017 / Notices 13353 Place: Teleconference—scheduled to The meeting will be open to the Fishers Lane, Rockville, MD 20892 begin at 3:00 p.m. Eastern Daylight public, with attendance limited to space which was published in the Federal Savings Time. To participate in the available. Individuals who plan to Register on February 14, 2017, 82 virtual meeting, please use the following attend and need special assistance, such 10581. URL http://www.ncvhs.hhs.gov/ that as sign language interpretation or other The meeting notice is amended to points to the NCVHS homepage. Further reasonable accommodations, should change the date from March 8, 2017 to information and meeting agenda will be notify the Contact Person listed below April 4, 2017. This meeting is closed to available on the NCVHS Web site in advance of the meeting. including instructions for accessing the the public. Name of Committee: Office of AIDS live meeting broadcast. Research Advisory Council. Dated: March 6, 2017. Status: Open by teleconference. There Date: April 6, 2017. Natasha M. Copeland, will be an open comment period during Time: 8:15 a.m. to 5:00 p.m. Program Analyst, Office of Federal Advisory the final 15 minutes of the virtual Agenda: OAR Director’s report; Update Committee Policy. from OARAC Working Groups for Treatment meeting. [FR Doc. 2017–04705 Filed 3–9–17; 8:45 am] and Prevention Guidelines; Report from Purpose: The purpose of this NCVHS November 2016 OARAC meeting; Report on BILLING CODE 4140–01–P virtual meeting is to discuss and as Continued Stakeholder Engagement; Update appropriate take action on: (1) NCVHS on HIV/AIDS research from the National 12th Report to Congress; (2) letter Heart, Lung, and Blood Institute; invited DEPARTMENT OF HEALTH AND assessing HealthData.gov, its early presentations and panel discussion on The HUMAN SERVICES successes and recommendations for Impact of the Microbiome in HIV Prevention maximizing its value; and (3) letter and Pathogenesis. National Institutes of Health Place: National Institutes of Health, focused on opportunities and Terrace Level Conference Center, 5635 approaches that HHS could employ to Fishers Lane, Rockville, MD 20852. National Institute of Arthritis and improve state, county, and local health Contact Person: Elizabeth S. Church, Ph.D., Musculoskeletal and Skin Diseases; officials’ ability to measure the health of Executive Secretary, Office of AIDS Research, Notice of Closed Meeting their populations at the community- DPCPSI, Office of the Director, 5601 Fishers level. The Committee also will continue Lane, Room 2E–60, Rockville, MD 20852– Pursuant to section 10(d) of the discussion in follow up to its June 2016 9830, 240–627–3201, elizabeth.church@ Federal Advisory Committee Act, as meeting on claims-based databases for nih.gov. amended (5 U.S.C. App.), notice is policy development and evaluation, Information is also available on the hereby given of the following meeting. including All-Payer Claims Databases. Institute’s/Center’s home page: www.oar.nih.gov, where an agenda and any The meeting will be closed to the Contact Person for more Information: additional information for the meeting will public in accordance with the Substantive program information may be posted when available. provisions set forth in sections be obtained from Rebecca Hines, MHS, (Catalogue of Federal Domestic Assistance 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Executive Secretary, NCVHS, National Program Nos. 93.14, Intramural Research as amended. The grant applications and Center for Health Statistics, Centers for Training Award; 93.22, Clinical Research the discussions could disclose Disease Control and Prevention, 3311 Loan Repayment Program for Individuals confidential trade secrets or commercial Toledo Road, Hyattsville, Maryland from Disadvantaged Backgrounds; 93.232, property such as patentable material, 20782, telephone (301) 458–4715. Loan Repayment Program for Research Generally; 93.39, Academic Research and personal information concerning Summaries of meetings and a roster of Enhancement Award; 93.936, NIH Acquired individuals associated with the grant Committee members are available on the Immunodeficiency Syndrome Research Loan applications, the disclosure of which NCVHS Web site: http:// Repayment Program; 93.187, Undergraduate would constitute a clearly unwarranted www.ncvhs.hhs.gov/, where further Scholarship Program for Individuals from information including an agenda and invasion of personal privacy. Disadvantaged Backgrounds, National instructions to access the audio Institutes of Health, HHS) Name of Committee: National Institute of broadcast of the meeting will be posted. Dated: March 6, 2017. Arthritis and Musculoskeletal and Skin Dated: March 2, 2017. Diseases Special Emphasis Panel; Ancillary Natasha M. Copeland, Studies. Laina Bush, Program Analyst, Office of Federal Advisory Date: March 27, 2017. Deputy Assistant Secretary for Planning and Committee Policy. Time: 10:00 a.m. to 1:00 p.m. Evaluation, Office of the Assistant Secretary [FR Doc. 2017–04703 Filed 3–9–17; 8:45 am] Agenda: To review and evaluate grant for Planning and Evaluation. BILLING CODE 4140–01–P applications. [FR Doc. 2017–04740 Filed 3–9–17; 8:45 am] Place: National Institute of Arthritis and BILLING CODE 4151–05–P Musculoskeletal and Skin Diseases, National DEPARTMENT OF HEALTH AND Institutes of Health, Democracy One, HUMAN SERVICES Bethesda, MD 20892 (Telephone Conference DEPARTMENT OF HEALTH AND Call). HUMAN SERVICES National Institutes of Health Contact Person: Yin Liu, Ph.D., MD, Scientific Review Officer, Scientific Review National Institutes of Health National Institute of Allergy and Branch, National Institute of Arthritis and Infectious Diseases Amended; Notice Musculoskeletal and Skin Diseases, NIH, sradovich on DSK3GMQ082PROD with NOTICES Office of the Director, National of Meeting Institutes of Health; Notice of Meeting 6701 Democracy Boulevard, Suite 824, Notice is hereby given of a change in Bethesda, MD 20892, 301–594–4952, liuy@ Pursuant to section 10(a) of the the meeting of the National Institute of exchange.nih.gov. Federal Advisory Committee Act, as Allergy and Infectious Diseases Special (Catalogue of Federal Domestic Assistance amended (5 U.S.C. App.), notice is Emphasis Panel, March 8, 2017, 1:00 Program Nos. 93.846, Arthritis, hereby given of a meeting of the Office p.m. to March 8, 2017, 5:00 p.m., Musculoskeletal and Skin Diseases Research, of AIDS Research Advisory Council. National Institutes of Health, 5601 National Institutes of Health, HHS) VerDate Sep<11>2014 18:37 Mar 09, 2017 Jkt 241001 PO 00000 Frm 00049 Fmt 4703 Sfmt 4703 E:\FR\FM\10MRN1.SGM 10MRN1

13354 Federal Register / Vol. 82, No. 46 / Friday, March 10, 2017 / Notices Dated: March 6, 2017. Agenda: To review and evaluate grant Time: 11:30 a.m. to 1:00 p.m. Sylvia L. Neal, applications. Agenda: To review and evaluate grant Program Analyst, Office of Federal Advisory Place: National Institutes of Health, 6701 applications. Rockledge Drive, Room 7180, Bethesda, MD Place: The William F. Bolger Center, 9600 Committee Policy. 20892 (Telephone Conference Call). Newbridge Drive, Potomac, MD 20854. [FR Doc. 2017–04710 Filed 3–9–17; 8:45 am] Contact Person: Tony L. Creazzo, Ph.D., Contact Person: Michael P. Reilly, Ph.D., BILLING CODE 4140–01–P Scientific Review Officer, Office of Scientific Scientific Review Officer, Office of Scientific Review/DERA, National Heart, Lung, and Review/DERA, National Heart, Lung, and Blood Institute, 6701 Rockledge Drive, Room Blood Institute, 6701 Rockledge Drive, Room DEPARTMENT OF HEALTH AND 7180, Bethesda, MD 20892–7924, 301–435– 7200, Bethesda, MD 20892, 301–827–7975, HUMAN SERVICES 0725, creazzotl@mail.nih.gov. reillymp@nhlbi.nih.gov. (Catalogue of Federal Domestic Assistance (Catalogue of Federal Domestic Assistance National Institutes of Health Program Nos. 93.233, National Center for Program Nos. 93.233, National Center for Sleep Disorders Research; 93.837, Heart and Sleep Disorders Research; 93.837, Heart and National Heart, Lung, and Blood Vascular Diseases Research; 93.838, Lung Vascular Diseases Research; 93.838, Lung Institute; Notice of Closed Meetings Diseases Research; 93.839, Blood Diseases Diseases Research; 93.839, Blood Diseases and Resources Research, National Institutes and Resources Research, National Institutes Pursuant to section 10(d) of the of Health, HHS) of Health, HHS) Federal Advisory Committee Act, as Dated: March 6, 2017. Dated: March 6, 2017. amended (5 U.S.C. App.), notice is Michelle Trout, Michelle Trout, hereby given of the following meetings. The meetings will be closed to the Program Analyst, Office of Federal Advisory Program Analyst, Office of Federal Advisory public in accordance with the Committee Policy. Committee Policy. provisions set forth in sections [FR Doc. 2017–04709 Filed 3–9–17; 8:45 am] [FR Doc. 2017–04708 Filed 3–9–17; 8:45 am] 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., BILLING CODE 4140–01–P BILLING CODE 4140–01–P as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial DEPARTMENT OF HEALTH AND DEPARTMENT OF HEALTH AND property such as patentable material, HUMAN SERVICES HUMAN SERVICES and personal information concerning National Institutes of Health National Institutes of Health individuals associated with the grant applications, the disclosure of which National Heart, Lung, and Blood National Heart, Lung, and Blood would constitute a clearly unwarranted Institute; Notice of Closed Meetings Institute; Notice of Closed Meeting invasion of personal privacy. Pursuant to section 10(d) of the Pursuant to section 10(d) of the Name of Committee: National Heart, Lung, and Blood Institute Special Emphasis Panel; Federal Advisory Committee Act, as Federal Advisory Committee Act, as Phase 1 and Phase 11, Bioreactors for amended (5 U.S.C. App.), notice is amended (5 U.S.C. App.), notice is Reparative Medicine (STTR). hereby given of the following meetings. hereby given of the following meetings. Date: March 30, 2017. The meetings will be closed to the The meetings will be closed to the Time: 2:00 p.m. to 2:30 p.m. public in accordance with the public in accordance with the Agenda: To review and evaluate grant provisions set forth in sections provisions set forth in sections applications. 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Place: National Institutes of Health, 6701 as amended. The grant applications and as amended. The grant applications and Rockledge Drive, Room 7180, Bethesda, MD 20892 (Telephone Conference Call). the discussions could disclose the discussions could disclose Contact Person: Tony L. Creazzo, Ph.D., confidential trade secrets or commercial confidential trade secrets or commercial Scientific Review Officer, Office of Scientific property such as patentable material, property such as patentable material, Review/DERA, National Heart, Lung, and and personal information concerning and personal information concerning Blood Institute, 6701 Rockledge Drive, Room individuals associated with the grant individuals associated with the grant 7180, Bethesda, MD 20892–7924, 301–435– applications, the disclosure of which applications, the disclosure of which 0725, creazzotl@mail.nih.gov. would constitute a clearly unwarranted would constitute a clearly unwarranted Name of Committee: National Heart, Lung, invasion of personal privacy. invasion of personal privacy. and Blood Institute Special Emphasis Panel; Phase 1 and Phase 11, Bioreactors for Name of Committee: National Heart, Lung, Name of Committee: National Heart, Lung, Reparative Medicine (SBIR). and Blood Institute Special Emphasis Panel; and Blood Institute Special Emphasis Panel; Date: March 30, 2017. Onsite Tools and Technology. Clinical Trials of Transplants for Blood Time: 2:30 p.m. to 3:00 p.m. Date: March 30, 2017. Diseases. Agenda: To review and evaluate grant Time: 11:00 a.m. to 2:00 p.m. Date: March 30–31, 2017. applications. Agenda: To review and evaluate grant Time: 8:00 a.m. to 11:00 a.m. Place: National Institutes of Health, 6701 applications. Agenda: To review and evaluate grant Rockledge Drive, Room 7180, Bethesda, MD Place: National Institutes of Health, 6701 applications. 20892 (Telephone Conference Call). Rockledge Drive, Room 7198, Bethesda, MD Place: The William F. Bolger Center, 9600 Contact Person: Tony L. Creazzo, Ph.D., 20892 (Telephone Conference Call). Newbridge Drive, Potomac, MD 20854. Scientific Review Officer, Office of Scientific Contact Person: Kristin Goltry, Ph.D., Contact Person: Michael P. Reilly, Ph.D., Review/DERA, National Heart, Lung, and Scientific Review Officer, Office of Scientific Scientific Review Officer, Office of Scientific Blood Institute, 6701 Rockledge Drive, Room Review/DERA, National Heart, Lung, and Review/DERA, National Heart, Lung, and sradovich on DSK3GMQ082PROD with NOTICES 7180, Bethesda, MD 20892–7924, 301–435– Blood Institute, 6701 Rockledge Drive, Room Blood Institute, 6701 Rockledge Drive, Room 0725, creazzotl@mail.nih.gov. 7198, Bethesda, MD 20892, 301–435–0297, 7200, Bethesda, MD 20892, 301–827–7975, Name of Committee: National Heart, Lung, goltrykl@mail.nih.gov. reillymp@nhlbi.nih.gov. and Blood Institute Special Emphasis Panel; Name of Committee: National Heart, Lung, Name of Committee: National Heart, Lung, SBIR Direct Phase II, Bioreactors for and Blood Institute Special Emphasis Panel; and Blood Institute Special Emphasis Panel; Reparative Medicine. Data Center for Clinical Trials of Transplants Translational Programs in Lung Diseases. Date: March 30, 2017. for Blood Diseases. Date: March 30–31, 2017. Time: 3:00 p.m. to 4:00 p.m. Date: March 31, 2017. Time: 12:30 p.m. to 3:00 p.m. VerDate Sep<11>2014 18:37 Mar 09, 2017 Jkt 241001 PO 00000 Frm 00050 Fmt 4703 Sfmt 4703 E:\FR\FM\10MRN1.SGM 10MRN1


Document Created: 2018-02-01 14:52:30
Document Modified: 2018-02-01 14:52:30
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
DatesMarch 27, 2017.
FR Citation82 FR 13353 
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR